Analytical Data
-
基因名
Clec2f
- Application
-
别名
C-type lectin domain family 2 member F; Clec2f; C-type lectin-related protein C (Clr-c); Clrc
-
种属
Mouse
-
表达系统
HEK293
-
标签
C-hFc
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q8VI21-1
-
表达区间
T63-C196
-
分子量
53-63 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Clec2f, or C-type lectin domain family 2 member F, is a member of the C-type lectin superfamily and plays an essential role in the immune response. Found predominantly in dendritic cells and macrophages, Clec2f has garnered attention for its involvement in the recognition of pathogens and the modulation of immune signaling pathways. Emerging research highlights its significance in both innate and adaptive immunity, revealing that Clec2f can influence cellular activation, differentiation, and cytokine production. Given its potential as a biomarker for immune-related diseases, including infections and autoimmune disorders, the study of Clec2f recombinant protein is increasingly relevant. Researchers are exploring its structure-function relationships, which could elucidate its mechanisms of action, and this knowledge may guide the development of novel therapeutics. Furthermore, Clec2f’s ability to facilitate the uptake of glycan-coated particles positions it as a promising target for vaccine development, enhancing antigen presentation and improving vaccine efficacy. Understanding the intricacies of Clec2f’s role in the immune system is critical, as it may lead to breakthroughs in controlling various diseases and informing strategies for immunotherapy. Consequently, the recombinant production of Clec2f not only serves as a vital tool for basic research but also holds promise for translational applications in medicine.












